LONG-TERM COST EFFECTIVENESS OF SIROLIMUS REGIMEN COMPARED WITH CALCINEURIN INHIBITOR REGIMENS FOR IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION IN KOREA

被引：0
|
作者：
Song, H. J. [1 ]
Park, S. Y. [1 ]
Kang, S. H. [1 ]
Bae, J. Y. [1 ]
Lee, E. K. [1 ]
机构：
[1] Sook Myung Womens Univ, Seoul, South Korea
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)74059-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A199 / A200
页数：2
相关论文
共 50 条
  • [31] Long-Term Sirolimus for Primary Immunosuppression is Associated With Decreased Incidence of Malignancies After Heart Transplantation
    Asleh, Rabea
    Pereira, Naveen L.
    Kremers, Walter
    Smith, Byron
    Li, Xin
    Edwards, Brooks S.
    Daly, Richard C.
    Kushwaha, Sudhir S.
    CIRCULATION, 2018, 138
  • [32] Long-Term Outcome and Cost Saving of Immunosuppression Withdrawal After Liver Transplantation
    Manzia, Tommaso Maria
    Angelico, Roberta
    Gherardi, Dario
    Tariciotti, Laura
    Toti, Luca
    Belardi, Chiara
    Quaranta, Claudia
    Lerut, Jan
    Tisone, Giuseppe
    TRANSPLANTATION, 2015, 99 : 130 - 130
  • [33] Adding an Antimetabolite to a Calcineurin-Inhibitor-Based Immunosuppression Regimen Leads to Improved Native Renal Function After Liver Transplantation
    Karim, A.
    Conway, D.
    Leverson, G.
    Mezrich, J.
    Fernandez, L.
    D'Alessandro, A.
    Foley, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 754 - 754
  • [34] Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation
    Schnitzler, MA
    Woodward, RS
    Lowell, JA
    Singer, GG
    Brennan, DC
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (3B) : 19S - 21S
  • [35] Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients
    Khandhar, Sameer J.
    Shah, Hemal V.
    Shullo, Michael A.
    Zomak, Rachelle
    Navoney, Michelle
    McNamara, Dennis M.
    Kormos, Robert L.
    Toyoda, Yoshiya
    Teuteberg, Jeffrey J.
    CLINICAL TRANSPLANTATION, 2012, 26 (01) : 42 - 49
  • [36] The renal benefit of calcineurin inhibitor-free immunosuppression after heart transplantation: Is it safe?
    Kobashigawa, JA
    Patel, JK
    Marquez, A
    Oeser, BT
    Moriguchi, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 193A - 193A
  • [37] Abatacept as Rescue Immunosuppression after Calcineurin Inhibitor Treatment Failure in Renal Transplantation.
    Badell, I. R.
    Vasanth, P.
    Farris, A. B.
    Robertson, J. M.
    Karadkhele, G. M.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 690 - 690
  • [38] Long-Term Outcomes Following a Calcineurin Sparing Protocol After Renal Transplantation.
    Soliman, K.
    Mogadam, E.
    Laftavi, M.
    Patel, S.
    Feng, L.
    Said, M.
    Pankewycz, O.
    TRANSPLANTATION, 2014, 98 : 540 - 540
  • [39] Early Steroid Withdrawal with a Sirolimus-and Mycophenolate-Based Calcineurin Inhibitor Minimization Regimen: Long-Term Results.
    Conti, J.
    Chandolias, N.
    Siparsky, N.
    Gallichio, M. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 441 - 442
  • [40] Immunosuppression and Long-Term Survival after Heart Transplantation
    Dandel, M.
    THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 : S148 - S150
12345